课题基金 / 基金详情

AUDITORY BRAINSTEM RESPONSE (ABR) ANALYSIS AND INTERPRETATION EXPERT SYSTEM

AUDITORY BRAINSTEM RESPONSE (ABR) ANALYSIS AND INTERPRETATION EXPERT SYSTEM
听觉脑干反应(ABR)分析和解释专家系统
批准号:
3896418
负责人:
J M DELEO
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

J M DELEO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this project has been to build an expert system to analyze and interpret the Auditory Brainstem Response (ABR), an electrophysiological response of the brainstem to acoustic stimuli. Expert reading of the ABR is essential in clinical decisions concerning retrocochlear disorders. We developed a rule-based expert system that performs neurodiagnostic interpretation of the auditory brainstem response. The system was developed on the IBM PC with the commercial expert system shell GURU and is now operational in the NIH audiology clinic. A talk entitled, "An Expert System Approach to Auditory Brainstem Response Interpretation", which describes our expert system was given at the 1988 American Audiologic Society Meeting in Boston. Experience in developing and using the system has suggested the possibility of generating more accurate ABR neurodiagnostic interpretation paradigms directly from ABR data using machine-learning methods. Accordingly, a study to derive diagnostic expert system rules directly from ABR data has been initiated. An abstract for a talk entitled, "Receiver Operating Characteristic Analysis of Auditory Brainstem Response Latency", has been submitted for presentation at the 1989 American Auditory Society Meeting in New Orleans. This talk covers our early experience with high-accuracy, data-derived rules for the critical differentiation of retrocochlear and cochlear disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BREAST CANCER PATIENT SURVIVAL PREDICTION--A NEURAL NETWORK APPROACH
AUDITORY BRAINSTEM RESPONSE (ABR) ANALYSIS AND INTERPRETATION EXPERT SYSTEM
BREAST CANCER PATIENT SURVIVAL PREDICTION--A NEURAL NETWORK APPROACH
COMPUTER ASSISTED PATIENT INTERVIEWING IN CLINICAL PHARMACY
海外基金